Samsung Bioepis G2GBio Obesity Drug Development Partnership Business & Economy Samsung Bioepis G2GBio Obesity Drug Development Partnership editor 3월 16, 2026 (Samsung Bioepis) Samsung Bioepis and Epis NexLab, subsidiaries of Samsung Epis Holdings, have announced a strategic joint...Read More
